Home-based treatment | |
Family training program [16] | |
Clinical care protocols | |
Risk assessment, measurement of blood loss, structured escalation and point-of-care viscoelastometric-guided early fibrinogen replacement [11] | |
Obstetric emergency team training | |
Co-ordination of and communication during emergencies [15], PPH kits [18] | |
First line treatment | |
E-MOTIVE: Early detection with calibrated drape plus ‘MOTIVE’ bundle [13] | |
Early diagnosis | |
Reusable calibrated postpartum blood collection tray [14] | |
Appropriate uterotonics [8] | |
Tranexamic acid | |
Intravenous (not oral [27]) tranexamic acid for PPH treatment [23], not caesarean prophylaxis [25] | |
Non-pneumatic anti-shock garment | |
Recommended by WHO [3] | |
Refractory PPH, non-surgical | |
Suction uterine tamponade devices [41, 42] versus balloon tamponade modifications [37] | |
Vaginal balloon tamponade [38] | |
Restrictive fluid resuscitation | |
Permissive hypotension to reduce blood loss [43] | |
Massive transfusion protocols [44] | |
Point-of-care viscoelastic haemostatic assay-guided blood product transfusion [48] | |
Pelvic artery embolization | |
Endovascular balloon occlusion of the aorta, common ileac arteries or internal ileac arteries [56] | |
External aortic compression | |
Recommended by WHO [2] | |
Direct compression of the aorta during laparotomy | |
Transvaginal haemostatic ligation procedures | |
Placental site sutures | |
Purse string technique [69] | |
Uterine compression sutures | |
Multiple variations described [71,72,73,74,75,76,77,78,79], including removable suture [80] | |
Innovative measures to control lower uterine segment haemorrhage associated with placenta accreta spectrum | |
‘Sandwich’ technique | |
B-LYNCH suture plus intrauterine balloon [86] | |
Uterine devascularization | |
Stepwise approach [88] | |
Cell salvage | |
High frequency focussed ultrasound for placenta increta | |
Promising [93] | |
Veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) | |